Photos of brand-name semaglutide (Ozempic, Wegovy) show clear, colorless liquid because brand-name products do not contain B12 or other color-producing additives
Novartis Pluvicto established radioligand therapy as a commercial reality (2022+): Lutetium-177 PSMA-617 (Pluvicto) for metastatic castration-resistant prostate cancer achieved rapid adoption post-2022 launch, validating the peptide receptor radionuclide therapy platform and creating a template for multiple follow-on radioligand therapy programmes
Retinoid discontinuation creates the benchmark comparison since topical vitamin A derivatives (tretinoin, adapalene, retinol) represent gold-standard anti-aging treatment with decades of research and user experience documenting post-treatment outcomes
Epitalon is scientifically more ambitious, directly targeting telomere maintenance through telomerase activation
The rationale for combining them is mechanistic complementarity (different signaling pathways, both implicated in tissue repair) and clinical anecdote in the peptide-therapy community not formal head-to-head or combination-vs-monotherapy data
A., Goncharova, N